These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1378 related items for PubMed ID: 17846270
1. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D. Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270 [Abstract] [Full Text] [Related]
2. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers. Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ. J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495 [Abstract] [Full Text] [Related]
3. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R. Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169 [Abstract] [Full Text] [Related]
4. Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment. Caselli RJ, Chen K, Lee W, Alexander GE, Reiman EM. Arch Neurol; 2008 Sep; 65(9):1231-6. PubMed ID: 18779428 [Abstract] [Full Text] [Related]
5. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, McArdle JJ, Moss M, Albert M. Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935 [Abstract] [Full Text] [Related]
6. Cognitive impairment in Alzheimer's disease is modified by APOE genotype. van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM. Dement Geriatr Cogn Disord; 2007 Jun; 24(2):98-103. PubMed ID: 17596691 [Abstract] [Full Text] [Related]
7. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH. Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913 [Abstract] [Full Text] [Related]
8. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Martins CA, Oulhaj A, de Jager CA, Williams JH. Neurology; 2005 Dec 27; 65(12):1888-93. PubMed ID: 16380608 [Abstract] [Full Text] [Related]
9. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS. Arch Neurol; 2005 Mar 27; 62(3):454-9. PubMed ID: 15767511 [Abstract] [Full Text] [Related]
10. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset. van der Vlies AE, Koedam EL, Pijnenburg YA, Twisk JW, Scheltens P, van der Flier WM. Psychol Med; 2009 Nov 27; 39(11):1907-11. PubMed ID: 19335933 [Abstract] [Full Text] [Related]
11. Impact of APOE status on cognitive maintenance in healthy elderly persons. Zehnder AE, Bläsi S, Berres M, Monsch AU, Stähelin HB, Spiegel R. Int J Geriatr Psychiatry; 2009 Feb 27; 24(2):132-41. PubMed ID: 18615849 [Abstract] [Full Text] [Related]
12. Association between ApoE epsilon4 and cognitive impairment after stroke. Wagle J, Farner L, Flekkøy K, Wyller TB, Sandvik L, Eiklid KL, Fure B, Stensrød B, Engedal K. Dement Geriatr Cogn Disord; 2009 Feb 27; 27(6):525-33. PubMed ID: 19494491 [Abstract] [Full Text] [Related]
13. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes. Caselli RJ, Reiman EM, Hentz JG, Osborne D, Alexander GE, Boeve BF. Sleep; 2002 Jun 15; 25(4):447-53. PubMed ID: 12071547 [Abstract] [Full Text] [Related]
14. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Arch Neurol; 2003 Oct 15; 60(10):1394-9. PubMed ID: 14568809 [Abstract] [Full Text] [Related]
15. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults. Pomara N, Willoughby L, Wesnes K, Greenblatt DJ, Sidtis JJ. Arch Gen Psychiatry; 2005 Feb 15; 62(2):209-16. PubMed ID: 15699298 [Abstract] [Full Text] [Related]
16. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. Portaccio E, Goretti B, Zipoli V, Nacmias B, Stromillo ML, Bartolozzi ML, Siracusa G, Guidi L, Federico A, Sorbi S, De Stefano N, Amato MP. Mult Scler; 2009 Dec 15; 15(12):1489-94. PubMed ID: 19965518 [Abstract] [Full Text] [Related]
17. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Knopman DS, Mosley TH, Catellier DJ, Coker LH, Atherosclerosis Risk in Communities Study Brain MRI Study. Alzheimers Dement; 2009 May 15; 5(3):207-14. PubMed ID: 19362884 [Abstract] [Full Text] [Related]
18. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Bäckman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L. Neurosci Lett; 2006 Mar 20; 396(1):23-7. PubMed ID: 16406347 [Abstract] [Full Text] [Related]
19. ApoE alleles and tau markers in patients with different levels of cognitive impairment. Lavados M, Farías G, Rothhammer F, Guillon M, Mujica MC, Maccioni C, Maccioni RB. Arch Med Res; 2005 Mar 20; 36(5):474-9. PubMed ID: 16099324 [Abstract] [Full Text] [Related]
20. The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology. Ramakers IH, Visser PJ, Aalten P, Bekers O, Sleegers K, van Broeckhoven CL, Jolles J, Verhey FR. Dement Geriatr Cogn Disord; 2008 Mar 20; 26(2):101-8. PubMed ID: 18617739 [Abstract] [Full Text] [Related] Page: [Next] [New Search]